According to data obtained through a whistleblower via a Freedom Of Information Act request, Australia\u2019s Therapeutic Goods Administration (TGA) and the New Zealand health authority responsible for ensuring medicines are safe for the public, published a report with redactions in Jan. 2021 admitting that mRNA particles don\u2019t just stay at the injection site but rapidly spread throughout the body.<\/p>\n
In one key finding in the study (\u201cNonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)\u201d), which documented rats post-Pfizer injection, researchers noted they observed distribution of lipid nanoparticles in plasma in the liver, adrenal glands, spleen and ovaries.<\/p>\n
\u201cOf course, the ovaries store and mature the ovum (female reproductive cells), so I\u2019m not gonna pretend I\u2019m not a little concerned about this, I\u2019m more than a little concerned actually,\u201d Dr. John Campbell noted.<\/p>\n
Another distressing section of the report notes \u201cslow but significant distribution of lipid nanoparticles from the site of injection with major uptake into liver.\u201c<\/p>\n
Dr. Campbell explained \u201cthat means the mRNA could go into the vascular endothelial cells in the liver into the hepatocytes themselves, produce the spike protein, that will be expressed, and there will be an inflammatory reaction against that spike protein in the liver.\u201d<\/p>\n
\u201cThis is not what we were told,\u201d Dr. Campbell emphasized.<\/p>\n
\u201cHow could the Australian health authorities know this back in 2021 and still approve this vaccine?\u201d he questioned.<\/p>\n
Here\u2019s a list of all the locations in the body concentrations of mRNA lipid nanoparticles were discovered, including the eyes, heart, pituitary gland and pancreas:<\/p>\n
\u201cGiven that this was known, why were the vaccines given authorization when they were?\u201d Dr. Campbell asked, concluding his report.<\/p>\n